{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:27:03Z","timestamp":1793320023433,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T00:00:00Z","timestamp":1697241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T00:00:00Z","timestamp":1697241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Health and Medical Research Fund (HMRF), the Food & Health Bureau of the HKSAR Government","award":["SMH-47"],"award-info":[{"award-number":["SMH-47"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Soc Psychiatry Psychiatr Epidemiol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00127-023-02563-4","type":"journal-article","created":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T03:25:13Z","timestamp":1697253913000},"page":"1215-1225","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Rates and correlates of medication non-adherence behaviors and attitudes in adult patients with early psychosis"],"prefix":"10.1007","volume":"59","author":[{"given":"Yuen Kiu","family":"So","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching Yui","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi Cheng","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsz Ting","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu Chun","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kit Wa","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Ming","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Yu","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai Ming","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing Chung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,14]]},"reference":[{"key":"2563_CR1","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","volume":"394","author":"M Huhn","year":"2019","unstructured":"Huhn M, Nikolakopoulou A, Schneider-Thoma J, Krause M, Samara M, Peter N et al (2019) Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet 394:939\u2013951","journal-title":"Lancet"},{"key":"2563_CR2","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S0140-6736(21)01997-8","volume":"399","author":"J Schneider-Thoma","year":"2022","unstructured":"Schneider-Thoma J, Chalkou K, D\u00f6rries C, Bighelli I, Ceraso A, Huhn M et al (2022) Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis. Lancet 399:824\u2013836","journal-title":"Lancet"},{"key":"2563_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0920-9964(97)00131-X","volume":"28","author":"JL Ayuso-Guti\u00e9rrez","year":"1997","unstructured":"Ayuso-Guti\u00e9rrez JL, del R\u00edo Vega JM (1997) Factors influencing relapse in the long-term course of schizophrenia. Schizophr Res 28:199\u2013206","journal-title":"Schizophr Res"},{"key":"2563_CR4","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.schres.2012.05.007","volume":"139","author":"M Alvarez-Jimenez","year":"2012","unstructured":"Alvarez-Jimenez M, Priede A, Hetrick SE, Bendall S, Killackey E, Parker AG et al (2012) Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies. Schizophr Res 139:116\u2013128","journal-title":"Schizophr Res"},{"key":"2563_CR5","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","volume":"374","author":"J Tiihonen","year":"2009","unstructured":"Tiihonen J, L\u00f6nnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A et al (2009) 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 374:620\u2013627","journal-title":"Lancet"},{"key":"2563_CR6","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/JCP.0b013e3181f058a0","volume":"30","author":"M Lambert","year":"2010","unstructured":"Lambert M, Conus P, Cotton S, Robinson J, McGorry PD, Schimmelmann BG (2010) Prevalence, predictors, and consequences of long-term refusal of antipsychotic treatment in first-episode psychosis. J Clin Psychopharmacol 30:565\u2013572","journal-title":"J Clin Psychopharmacol"},{"key":"2563_CR7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1177\/2045125312474019","volume":"3","author":"K Higashi","year":"2013","unstructured":"Higashi K, Medic G, Littlewood KJ, Diez T, Granstr\u00f6m O, De Hert M (2013) Medication adherence in schizophrenia: Factors influencing adherence and consequences of nonadherence, a systematic literature review. Ther Adv Psychopharmacol 3:200\u2013218","journal-title":"Ther Adv Psychopharmacol"},{"key":"2563_CR8","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1590\/1516-4446-2014-1539","volume":"37","author":"E Leclerc","year":"2015","unstructured":"Leclerc E, Noto C, Bressan RA, Brietzke E (2015) Determinants of adherence to treatment in first-episode psychosis: a comprehensive review. Braz J Psychiatry 37:168\u2013176","journal-title":"Braz J Psychiatry"},{"key":"2563_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.531763","volume":"14","author":"EI Abdellati","year":"2020","unstructured":"Abdellati EI, K, De Picker L, Morrens M, (2020) Antipsychotic treatment failure: a systematic review on risk factors and interventions for treatment adherence in psychosis. Front Neurosci 14:531763","journal-title":"Front Neurosci"},{"key":"2563_CR10","doi-asserted-by":"publisher","unstructured":"St\u00fcrup AE, Nordentoft M, Jimenez-Solem E, Osler M, Davy JW, Christensen TN et al (2022) Discontinuation of antipsychotics in individuals with first-episode schizophrenia and its association to functional outcomes, hospitalization and death: a register-based nationwide follow-up study. Psychol Med. https:\/\/doi.org\/10.1017\/S0033291722002021","DOI":"10.1017\/S0033291722002021"},{"issue":"S33","key":"2563_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1192\/S0007125000297663","volume":"172","author":"M Birchwood","year":"1998","unstructured":"Birchwood M, Todd P, Jackson C (1998) Early intervention in psychosis: the critical period hypothesis. Br J Psychiatry 172(S33):53\u201359","journal-title":"Br J Psychiatry"},{"key":"2563_CR12","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1034\/j.1600-0447.2002.02437.x","volume":"106","author":"E Coldham","year":"2002","unstructured":"Coldham E, Addington J, Addington D (2002) Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand 106:286\u2013290","journal-title":"Acta Psychiatr Scand"},{"key":"2563_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1185\/030079907X162665","volume":"23","author":"SL Tunis","year":"2007","unstructured":"Tunis SL, Faries DE, Stensland MD, Hay DP, Kinon BJ (2007) An examination of factors affecting persistence with initial antipsychotic treatment in patients with schizophrenia. Curr Med Res Opin 23:97\u2013104","journal-title":"Curr Med Res Opin"},{"key":"2563_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1751-7893.2008.00108.x","volume":"3","author":"PL Quach","year":"2009","unstructured":"Quach PL, Mors O, Christensen TO, Krarup G, J\u00f8rgensen P, Bertelsen M et al (2009) Predictors of poor adherence to medication among patients with first-episode schizophrenia-spectrum disorder. Early Interv Psychiatry 3:66\u201374","journal-title":"Early Interv Psychiatry"},{"key":"2563_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/070674370905400106","volume":"54","author":"M Rabinovitch","year":"2009","unstructured":"Rabinovitch M, B\u00e9chard-Evans L, Schmitz N, Joober R, Malla A (2009) Early predictors of nonadherence to antipsychotic therapy in first-episode psychosis. Can J Psychiatry 54:28\u201335","journal-title":"Can J Psychiatry"},{"key":"2563_CR16","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.schres.2011.04.030","volume":"130","author":"V Baloush-Kleinman","year":"2011","unstructured":"Baloush-Kleinman V, Levine SZ, Roe D, Shnitt D, Weizman A, Poyurovsky M (2011) Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study. Schizophr Res 130:176\u2013181","journal-title":"Schizophr Res"},{"key":"2563_CR17","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/JCP.0b013e31825d3763","volume":"32","author":"TC Montreuil","year":"2012","unstructured":"Montreuil TC, Cassidy CM, Rabinovitch M, Pawliuk N, Schmitz N, Joober R et al (2012) Case manager- and patient-rated alliance as a predictor of medication adherence in first-episode psychosis. J Clin Psychopharmacol 32:465\u2013469","journal-title":"J Clin Psychopharmacol"},{"key":"2563_CR18","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1046\/j.0001-690X.2003.00193.x","volume":"108","author":"SH Mutsatsa","year":"2003","unstructured":"Mutsatsa SH, Joyce EM, Hutton SB, Webb E, Gibbins H, Paul S et al (2003) Clinical correlates of early medication adherence: West London first episode schizophrenia study. Acta Psychiatr Scand 108:439\u2013446","journal-title":"Acta Psychiatr Scand"},{"key":"2563_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1176\/ps.2010.61.2.189","volume":"61","author":"M Hill","year":"2010","unstructured":"Hill M, Crumlish N, Whitty P, Clarke M, Browne S, Kamali M et al (2010) Nonadherence to medication four years after a first episode of psychosis and associated risk factors. Psychiatr Serv 61:189\u2013192","journal-title":"Psychiatr Serv"},{"key":"2563_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.schres.2016.09.029","volume":"179","author":"TT Winton-Brown","year":"2017","unstructured":"Winton-Brown TT, Elanjithara T, Power P, Coentre R, Blanco-Polaina P, McGuire P (2017) Five-fold increased risk of relapse following breaks in antipsychotic treatment of first episode psychosis. Schizophr Res 179:50\u201356","journal-title":"Schizophr Res"},{"key":"2563_CR21","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/eip.12559","volume":"13","author":"C Tan","year":"2019","unstructured":"Tan C, Abdin E, Liang W, Poon LY, Poon NY, Verma S (2019) Medication adherence in first-episode psychosis patients in Singapore. Early Interv Psychiatry 13:780\u2013788","journal-title":"Early Interv Psychiatry"},{"key":"2563_CR22","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.schres.2016.03.026","volume":"174","author":"CLM Hui","year":"2016","unstructured":"Hui CLM, Poon VWY, Ko WT, Miao HY, Chang WC, Lee EHM et al (2016) Risk factors for antipsychotic medication non-adherence behaviors and attitudes in adult-onset psychosis. Schizophr Res 174:144\u2013149","journal-title":"Schizophr Res"},{"key":"2563_CR23","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s00127-016-1221-8","volume":"51","author":"ESM Chen","year":"2016","unstructured":"Chen ESM, Chang WC, Hui CLM, Chan SKW, Lee EHM, Chen EYH (2016) Self-stigma and affiliate stigma in first-episode psychosis patients and their caregivers. Soc Psychiatry Psychiatr Epidemiol 51:1225\u20131231","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"2563_CR24","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.schres.2017.09.004","volume":"195","author":"RWH Ho","year":"2018","unstructured":"Ho RWH, Chang WC, Kwong VWY, Lau ESK, Chan GHK, Jim OTT et al (2018) Prediction of self-stigma in early psychosis: 3-year follow-up of the randomized-controlled trial on extended early intervention. Schizophr Res 195:463\u2013468","journal-title":"Schizophr Res"},{"key":"2563_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.cpr.2016.10.009","volume":"51","author":"M Wade","year":"2017","unstructured":"Wade M, Tai S, Awenat Y, Haddock G (2017) A systematic review of service-user reasons for adherence and nonadherence to neuroleptic medication in psychosis. Clin Psychol Rev 51:75\u201395","journal-title":"Clin Psychol Rev"},{"key":"2563_CR26","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00127-012-0570-1","volume":"48","author":"M Richardson","year":"2013","unstructured":"Richardson M, McCabe R, Priebe S (2013) Are attitudes towards medication adherence associated with medication adherence behaviors among patients with psychosis? A systematic review and meta-analysis. Soc Psychiatry Psychiatr Epidemiol 48:649\u2013657","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"2563_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11126-018-9618-z","volume":"90","author":"L Kondr\u00e1tov\u00e1","year":"2019","unstructured":"Kondr\u00e1tov\u00e1 L, K\u00f6nig D, Mlad\u00e1 K, Winkler P (2019) Correlates of negative attitudes towards medication in people with schizophrenia. Psychiatr Q 90:159\u2013169","journal-title":"Psychiatr Q"},{"key":"2563_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12888-021-03037-0","volume":"21","author":"J Leijala","year":"2021","unstructured":"Leijala J, Kampman O, Suvisaari J, Eskelinen S (2021) Daily functioning and symptom factors contributing to attitudes toward antipsychotic treatment and treatment adherence in outpatients with schizophrenia spectrum disorders. BMC Psychiatry 21:37","journal-title":"BMC Psychiatry"},{"key":"2563_CR29","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.schres.2011.11.008","volume":"134","author":"J Yang","year":"2012","unstructured":"Yang J, Ko YH, Paik JW, Lee MS, Han C, Joe SH et al (2012) Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia. Schizophr Res 134:226\u2013231","journal-title":"Schizophr Res"},{"key":"2563_CR30","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/schbul\/sbv015","volume":"41","author":"RJ Drake","year":"2015","unstructured":"Drake RJ, Nordentoft M, Haddock G, Arango C, Fleischhacker WW, Glenth\u00f8j B et al (2015) Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for intervention. Schizophr Bull 41:584\u2013595","journal-title":"Schizophr Bull"},{"key":"2563_CR31","doi-asserted-by":"publisher","first-page":"781","DOI":"10.2147\/NDT.S240377","volume":"16","author":"N Nagai","year":"2020","unstructured":"Nagai N, Tani H, Yoshida K, Gerretsen P, Suzuki T, Ikai-Tani S et al (2020) Drug attitude, insight, and patient\u2019s knowledge about prescribed antipsychotics in schizophrenia: a cross-sectional survey. Neuropsychiatr Dis Treat 16:781\u2013787","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2563_CR32","doi-asserted-by":"crossref","unstructured":"Chang WC, Ho C, Or CF, Liu TT, Lau CF, Chu OK et al (2018) Treatment delay and outcome comparison of extended early intervention service and standard psychiatric care for adults presenting with first-episode psychosis in Hong Kong. Schizophr Bull 44(Suppl. 1):S215","DOI":"10.1093\/schbul\/sby016.528"},{"key":"2563_CR33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1515\/9789888180875-009","volume-title":"Early psychosis intervention: a cultural adaptive clinical guide","author":"DWS Chung","year":"2013","unstructured":"Chung DWS, Chen EYH (2013) Urban setting: EASY and other services in Hong Kong. In: Chen EYH, Lee H, Chan GHK, Wong GHY (eds) Early psychosis intervention: a cultural adaptive clinical guide. Hong Kong University Press, Hong Kong, pp 17\u201327"},{"key":"2563_CR34","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1751-7893.2011.00279.x","volume":"5","author":"EYH Chen","year":"2011","unstructured":"Chen EYH, Tang JYM, Hui CLM, Chiu CP, Lam MM, Law CW et al (2011) Three-year outcome of phase-specific early intervention for first-episode psychosis: a cohort study in Hong Kong. Early Interv Psychiatry 5:315\u2013323","journal-title":"Early Interv Psychiatry"},{"key":"2563_CR35","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1192\/bjp.bp.114.150144","volume":"206","author":"WC Chang","year":"2015","unstructured":"Chang WC, Chan GHK, Jim OTT, Lau ESK, Hui CLM, Chan SKW et al (2015) Optimal duration of an early intervention for first-episode psychosis: randomised controlled trial. Br J Psychiatry 206:492\u2013500","journal-title":"Br J Psychiatry"},{"key":"2563_CR36","first-page":"7","volume":"13","author":"E So","year":"2003","unstructured":"So E, Kam I, Leung C, Chung D, Liu Z, Fong S (2003) The Chinese-bilingual SCID-I\/P project: stage 1\u2014reliability for mood disorders and schizophrenia. HK J Psychiatry 13:7\u201318","journal-title":"HK J Psychiatry"},{"key":"2563_CR37","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/schbul\/8.3.470","volume":"8","author":"HE Cannon-Spoor","year":"1982","unstructured":"Cannon-Spoor HE, Potkin SG, Wyatt RJ (1982) Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 8:470\u2013484","journal-title":"Schizophr Bull"},{"key":"2563_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/oxfordjournals.schbul.a006858","volume":"27","author":"DN Allen","year":"2001","unstructured":"Allen DN, Kelley ME, Miyatake RK, Gurklis JA Jr, Van Kammen DP (2001) Confirmation of a two-factor model of premorbid adjustment in males with schizophrenia. Schizophr Bull 27:39\u201346","journal-title":"Schizophr Bull"},{"key":"2563_CR39","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.psychres.2013.02.014","volume":"209","author":"WC Chang","year":"2013","unstructured":"Chang WC, Tang JYM, Hui CLM, Wong GHY, Chan SKW, Lee EHM et al (2013) The relationship of early premorbid adjustment with negative symptoms and cognitive functions in first-episode schizophrenia: a prospective three-year follow-up study. Psychiatry Res 209:353\u2013360","journal-title":"Psychiatry Res"},{"key":"2563_CR40","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0920-9964(92)90004-O","volume":"6","author":"H H\u00e4fner","year":"1992","unstructured":"H\u00e4fner H, Riecher-R\u00f6ssler A, Hambrecht M, Maurer K, Meissner S, Schmidtke A et al (1992) IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophr Res 6:209\u2013223","journal-title":"Schizophr Res"},{"key":"2563_CR41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261\u2013276","journal-title":"Schizophr Bull"},{"key":"2563_CR42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0920-9964(02)00302-X","volume":"61","author":"R Emsley","year":"2003","unstructured":"Emsley R, Rabinowitz J, Torreman M (2003) The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis. Schizophr Res 61:47\u201357","journal-title":"Schizophr Res"},{"key":"2563_CR43","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/schbul\/sbq059","volume":"37","author":"B Kirkpatrick","year":"2011","unstructured":"Kirkpatrick B, Strauss G, Nguyen L, Fischer BA, Daniel DG, Cienfuegos A et al (2011) The Brief Negative Symptom Scale: psychometric properties. Schizophr Bull 37:300\u2013305","journal-title":"Schizophr Bull"},{"key":"2563_CR44","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.schres.2012.09.007","volume":"142","author":"GP Strauss","year":"2012","unstructured":"Strauss GP, Hong LE, Gold JM, Buchanan RW, McMahon RP, Keller WR et al (2012) Factor structure of the brief negative symptom scale. Schizophr Res 142:96\u201398","journal-title":"Schizophr Res"},{"key":"2563_CR45","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1017\/S0033291719002769","volume":"50","author":"WC Chang","year":"2020","unstructured":"Chang WC, Westbrook A, Strauss GP, Chu AOK, Chong CSY, Siu CMW et al (2020) Abnormal cognitive effort allocation and its association with amotivation in first-episode psychosis. Psychol Med 50:2599\u20132609","journal-title":"Psychol Med"},{"key":"2563_CR46","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0920-9964(90)90005-R","volume":"3","author":"D Addington","year":"1990","unstructured":"Addington D, Addington J, Schissel B (1990) A depression rating scale for schizophrenics. Schizophr Res 3:247\u2013251","journal-title":"Schizophr Res"},{"key":"2563_CR47","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1176\/ajp.150.6.873","volume":"150","author":"XF Amador","year":"1993","unstructured":"Amador XF, Strauss DH, Yale SA, Flaum MM, Endicott J, Gorman JM (1993) Assessment of insight in psychosis. Am J Psychiatry 150:873\u2013879","journal-title":"Am J Psychiatry"},{"key":"2563_CR48","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1939-0025.2010.01030.x","volume":"80","author":"WWS Mak","year":"2010","unstructured":"Mak WWS, Cheung RYM (2010) Self-stigma among concealable minorities in Hong Kong: conceptualization and unified measurement. Am J Orthopsychiatry 80:267\u2013281","journal-title":"Am J Orthopsychiatry"},{"key":"2563_CR49","unstructured":"Marshall GN, Hays RD (1994) The Patient Satisfaction Questionnaire Short Form (PSQ-18). RAND, Santa Monica, CA"},{"issue":"S212","key":"2563_CR50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","volume":"45","author":"GM Simpson","year":"1970","unstructured":"Simpson GM, Angus JWS (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 45(S212):11\u201319","journal-title":"Acta Psychiatr Scand"},{"key":"2563_CR51","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1192\/bjp.154.5.672","volume":"154","author":"TRE Barnes","year":"1989","unstructured":"Barnes TRE (1989) A rating scale for drug-induced akathisia. Br J Psychiatry 154:672\u2013676","journal-title":"Br J Psychiatry"},{"key":"2563_CR52","unstructured":"Guy WECDEU (1976) Assessment Manual for Psychopharmacology, revised. US Department of Health, Education, and Welfare Publication (ADM), Rockville, MD"},{"key":"2563_CR53","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0920-9964(99)00130-9","volume":"42","author":"K Thompson","year":"2000","unstructured":"Thompson K, Kulkarni J, Sergejew AA (2000) Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res 42:241\u2013247","journal-title":"Schizophr Res"},{"key":"2563_CR54","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S2215-0366(18)30090-7","volume":"5","author":"CLM Hui","year":"2018","unstructured":"Hui CLM, Honer W, Lee EHM, Chang WC, Chan SKW, Chen ESM et al (2018) Long-term effects of discontinuation from antipsychotic maintenance following first-episode schizophrenia and related disorders: a 10 year follow-up of a randomised double-blind trial. Lancet Psychiatry 5:432\u2013442","journal-title":"Lancet Psychiatry"},{"key":"2563_CR55","volume-title":"Multivariate data analysis","author":"JF Hair","year":"2010","unstructured":"Hair JF, Black WC, Babin BJ, Anderson RE (2010) Multivariate data analysis, 7th edn. Prentice Hall, Upper Saddle River","edition":"7"},{"key":"2563_CR56","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.2147\/PPA.S99136","volume":"10","author":"D Kamaradova","year":"2016","unstructured":"Kamaradova D, Latalova K, Prasko J, Kubinek R, Vrbova K, Mainerova B et al (2016) Connection between self-stigma, adherence to treatment, and discontinuation of medication. Patient Prefer Adherence 10:1289\u20131298","journal-title":"Patient Prefer Adherence"},{"key":"2563_CR57","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/S0277-9536(98)00209-3","volume":"47","author":"A Rogers","year":"1998","unstructured":"Rogers A, Day JC, Williams B, Randall F, Wood P, Healy D et al (1998) The meaning and management of neuroleptic medication: a study of patients with a diagnosis of schizophrenia. Soc Sci Med 47:1313\u20131323","journal-title":"Soc Sci Med"},{"key":"2563_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-244X-13-168","volume":"13","author":"S Teferra","year":"2013","unstructured":"Teferra S, Hanlon C, Beyero T, Jacobsson L, Shibre T (2013) Perspectives on reasons for non-adherence to medication in persons with schizophrenia in Ethiopia: a qualitative study of patients, caregivers and health workers. BMC Psychiatry 13:1\u20139","journal-title":"BMC Psychiatry"},{"key":"2563_CR59","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00127-014-0930-0","volume":"50","author":"SKW Chan","year":"2015","unstructured":"Chan SKW, Wong MHM, Hui CLM, Lee EHM, Chang WC, Chen EYH (2015) Perceived risk of relapse and role of medication: comparison between patients with psychosis and their caregivers. Soc Psychiatry Psychiatr Epidemiol 50:307\u2013315","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"2563_CR60","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.psychres.2018.01.012","volume":"261","author":"T Feldhaus","year":"2018","unstructured":"Feldhaus T, Falke S, von Gruchalla L, Maisch B, Uhlmann C, Bock E et al (2018) The impact of self-stigmatization on medication attitude in schizophrenia patients. Psychiatry Res 261:391\u2013399","journal-title":"Psychiatry Res"},{"key":"2563_CR61","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00406-017-0829-3","volume":"268","author":"YJ Lien","year":"2018","unstructured":"Lien YJ, Chang HA, Kao YC, Tzeng NS, Lu CW, Loh CH (2018) The impact of cognitive insight, self-stigma, and medication compliance on the quality of life in patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci 268:27\u201338","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2563_CR62","doi-asserted-by":"crossref","unstructured":"Castagnini AC, Fusar-Poli P (2017) Diagnostic validity of ICD-10 acute and transient psychotic disorders and DSM-5 brief psychotic disorder Eur Psychiatry 45:104\u2013113","DOI":"10.1016\/j.eurpsy.2017.05.028"},{"key":"2563_CR63","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11920-019-1099-8","volume":"21","author":"S Malhotra","year":"2019","unstructured":"Malhotra S, Sahoo S, Balachander S (2019) Acute and transient psychotic disorders: new understanding. Curr Psychiatry Rep 21:113","journal-title":"Curr Psychiatry Rep"},{"key":"2563_CR64","volume-title":"Delusional disorder. Paranoia and related illnesses","author":"A Munro","year":"1991","unstructured":"Munro A (1991) Delusional disorder. Paranoia and related illnesses. Cambridge University Press, Cambridge"},{"key":"2563_CR65","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/schbul\/sbq125","volume":"38","author":"A Marneros","year":"2012","unstructured":"Marneros A, Pillman F, Wustmann T (2012) Delusional disorders\u2014are they simply paranoid schizophrenia? Schizophr Bull 38:561\u2013568","journal-title":"Schizophr Bull"},{"key":"2563_CR66","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/JCP.0b013e31825d3763","volume":"32","author":"TC Montreuil","year":"2012","unstructured":"Montreuil TC, Cassidy CM, Rabinovitch M, Pawliuk N, Schmitz N, Joober R (2012) Case manager- and patient-related alliance as a predictor of medication adherence in first-episode psychosis. J Clin Psychophmarcol 32:465\u2013469","journal-title":"J Clin Psychophmarcol"},{"key":"2563_CR67","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/JCP.0000000000001449","volume":"41","author":"M Lim","year":"2021","unstructured":"Lim M, Li Z, Xie H, Tan BL, Lee J (2021) The effect of therapeutic alliance on attitude toward psychiatric medications in schizophrenia. J Clin Psychopharmacol 41:551\u2013560","journal-title":"J Clin Psychopharmacol"},{"key":"2563_CR68","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.schres.2021.04.002","volume":"231","author":"J Browne","year":"2021","unstructured":"Browne J, Wright AC, Berry K, Mueser KT, Cather C, Penn DL, Kurtz MM (2021) The alliance-outcome relationship in individual psychosocial treatment for schizophrenia and early psychosis: a meta-analysis. Schizophr Res 231:154\u2013163","journal-title":"Schizophr Res"},{"key":"2563_CR69","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0920-9964(02)00314-6","volume":"63","author":"SD Jeste","year":"2003","unstructured":"Jeste SD, Patterson TL, Palmer BW, Dolder CR, Goldman S, Jeste DV (2003) Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia. Schizophr Res 63:49\u201358","journal-title":"Schizophr Res"},{"key":"2563_CR70","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jpsychires.2015.09.006","volume":"70","author":"A El-Missiry","year":"2015","unstructured":"El-Missiry A, Elbatrawy A, El Missiry M, Moneim DA, Ali R, Essawy H (2015) Comparing cognitive functions in medication adherent and non-adherent patients with schizophrenia. J Psychiatr Res 70:106\u2013112","journal-title":"J Psychiatr Res"},{"key":"2563_CR71","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.psychres.2014.08.046","volume":"220","author":"CLM Hui","year":"2014","unstructured":"Hui CLM, Li AWY, Leung CM, Chang WC, Chan SK, Lee EH et al (2014) Comparing illness presentation, treatment and functioning between patients with adolescent- and adult-onset psychosis. Psychiatry Res 220:797\u2013802","journal-title":"Psychiatry Res"},{"key":"2563_CR72","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/JCP.0b013e3181ca03df","volume":"30","author":"CM Cassidy","year":"2010","unstructured":"Cassidy CM, Rabinovitch M, Schmitz N, Joober R, Malla A (2010) A comparison study of multiple measures of adherence to antipsychotic medication in first-episode psychosis. J Clin Psychopharmacol 30:64\u201367","journal-title":"J Clin Psychopharmacol"}],"container-title":["Social Psychiatry and Psychiatric Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00127-023-02563-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00127-023-02563-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00127-023-02563-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T20:50:45Z","timestamp":1730321445000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00127-023-02563-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,14]]},"references-count":72,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["2563"],"URL":"https:\/\/doi.org\/10.1007\/s00127-023-02563-4","relation":{},"ISSN":["0933-7954","1433-9285"],"issn-type":[{"value":"0933-7954","type":"print"},{"value":"1433-9285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,14]]},"assertion":[{"value":"21 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Author E.Y.H.C has participated in the scientific advisory board for Otsuka, has received educational grant support from Janssen-Cilag, and has received research funding from Astra-Zeneca, Janssen-Cilag, Eli Lilly, Sanofi-Aventis and Otsuka. The authors report no conflict of interest. The authors alone are responsible for the content and writing of the paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}